Method For Preventing Progression To Metabolic Syndrome

Fahd Al-Mulla; Rasheeba Nizam; Ashraf Al Madhoun

Method For Preventing Progression To Metabolic Syndrome

Fahd Al-Mulla (Inventor), Rasheeba Nizam (Inventor), Ashraf Al Madhoun (Inventor)

Research output: Patent

Abstract

The method for preventing progression to metabolic syndrome includes determining whether a subject possesses at least one allele of the caveolin-1 rs1997623 C to A SNP, and providing an intervention to prevent progression to metabolic syndrome, including modifications of diet and exercise, administration of one or more pharmaceutical compounds, or a combination thereof. The method may be useful to reduce the risk of developing complications associated with MetS, such as heart disease, stroke, or diabetes. The method may include monitoring additional metabolic risk factors. The pharmaceutical compound may be a pharmaceutical capable of inhibiting the expression of caveolin-1.

Original language	English
Patent number	10,731,219, B1
IPC	US
Filing date	19/09/19
Publication status	Published - 4 Aug 2020

Keywords

Metabolic syndrome

Fingerprint Dive into the research topics of 'Method For Preventing Progression To Metabolic Syndrome'. Together they form a unique fingerprint.

Cite this

@misc{170c8eff944b4d3285207ca95932920f,

title = "Method For Preventing Progression To Metabolic Syndrome",

abstract = "The method for preventing progression to metabolic syndrome includes determining whether a subject possesses at least one allele of the caveolin-1 rs1997623 C to A SNP, and providing an intervention to prevent progression to metabolic syndrome, including modifications of diet and exercise, administration of one or more pharmaceutical compounds, or a combination thereof. The method may be useful to reduce the risk of developing complications associated with MetS, such as heart disease, stroke, or diabetes. The method may include monitoring additional metabolic risk factors. The pharmaceutical compound may be a pharmaceutical capable of inhibiting the expression of caveolin-1.",

keywords = "Metabolic syndrome",

author = "Fahd Al-Mulla and Rasheeba Nizam and {Al Madhoun}, Ashraf",

year = "2020",

month = aug,

day = "4",

language = "English",

type = "Patent",

note = "10,731,219, B1; US",

}

TY - PAT

T1 - Method For Preventing Progression To Metabolic Syndrome

AU - Al-Mulla, Fahd

AU - Nizam, Rasheeba

AU - Al Madhoun, Ashraf

PY - 2020/8/4

Y1 - 2020/8/4

N2 - The method for preventing progression to metabolic syndrome includes determining whether a subject possesses at least one allele of the caveolin-1 rs1997623 C to A SNP, and providing an intervention to prevent progression to metabolic syndrome, including modifications of diet and exercise, administration of one or more pharmaceutical compounds, or a combination thereof. The method may be useful to reduce the risk of developing complications associated with MetS, such as heart disease, stroke, or diabetes. The method may include monitoring additional metabolic risk factors. The pharmaceutical compound may be a pharmaceutical capable of inhibiting the expression of caveolin-1.

AB - The method for preventing progression to metabolic syndrome includes determining whether a subject possesses at least one allele of the caveolin-1 rs1997623 C to A SNP, and providing an intervention to prevent progression to metabolic syndrome, including modifications of diet and exercise, administration of one or more pharmaceutical compounds, or a combination thereof. The method may be useful to reduce the risk of developing complications associated with MetS, such as heart disease, stroke, or diabetes. The method may include monitoring additional metabolic risk factors. The pharmaceutical compound may be a pharmaceutical capable of inhibiting the expression of caveolin-1.

KW - Metabolic syndrome

M3 - Patent

M1 - 10,731,219, B1

Y2 - 2019/09/19

ER -